60 results

AstraZeneca chief executive Pascal Soriot said he had no regrets over getting involved in Covid-19 vaccines as the company has made an “enormous difference”. Photograph: iStock

AstraZeneca is exploring options for the future of its Covid-19 vaccine and expects greater clarity on the matter by the end of 2021, a senior executi(...)

Concerns about higher inflation and rising Covid-19 infections causing a slowdown have weighed on investors’ minds this week. File Photograph: Getty

Global shares edged lower while US Treasury yields hovered near multi-month lows on Friday. Concerns about surging Covid-19 cases weighed on sentimen(...)

The S&P retreated from a record high on Wednesday afternoon. Photograph: Angela Weiss/AFP

European shares recovered most of their day’s losses to remain near record highs on Wednesday after a dovish tone from the US Federal Reserve calmed (...)

In London, Greencore’s share price slumped by more than 15 per cent. Photograph: Cyril Byrne

European stocks closed flat on Tuesday, as a billion-dollar German property deal and a rally in technology shares were offset by losses in major minin(...)

AstraZeneca chief executive Pascal Soriot. Photograph: Toby Melville/File Photo/Reuters

AstraZeneca chief executive Pascal Soriot has suffered a shareholder rebellion on pay after the pharmaceutical company significantly increased his pot(...)

A vial of the Oxford/AstraZeneca coronavirus vaccine. Photograph:  Yui Mok/PA Wire

AstraZeneca expects profit growth to pick up this year after the Covid-19 vaccine developer beat forecasts for quarterly drug sales, with demand for i(...)

Kerry Group saw its shares decline further to €120.90, a 0.33 per cent decline

Shares rose on Monday as a decision to extend trade talks between the UK and the European Union kept hopes of an eventual deal alive. Hopes of an end(...)

Chief executive Pascal Soriot  has made AstraZeneca one of the pharmaceutical world’s success stories, raising profits and broadening its portfolio

AstraZeneca shares fell as much as 9 per cent on Monday as investors moved to price in the costs of a $39 billion (€32bn) deal for US biotech company (...)

The Covid Alliance imported the raw materials for lysis buffer into the country last month as reagent shortages held back the State’s testing programme

A group of biopharma companies, working with academics and individuals in the sector, has manufactured enough of a key component used in Covid-19 test(...)

Halo Business Angel Network in Powerscourt, Co Wicklow

Monday, February 3rd Results: Ryanair, Alphabet, Alexion Pharmaceuticals, Viacom. Indicators: Euro zone manufacturing PMI (Jan); UK manufacturing PMI(...)

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • Next
  • Last »